126 Transverse B-Lynch versus multiple 8 compression sutures for uterine preservation in patients with placenta accreta 
OBJECTIVE:
The study aims to compare the effectiveness of transverse B-Lynch and multiple 8 compression sutures as a conservative procedure in patients with placenta accreta asking for uterine preservation STUDY DESIGN: Our study was a prospective cohort study conducted in single tertiary University Hospital from January 2017 to May 2018. All pregnant women diagnosed as placenta previa with high suspicion of placenta accreta by 2D ultrasonography and color Doppler performed by an expert level II sonographer were enrolled in the study. Inclusion was based on patients' request to conserve their uteri for fertility preservation. A written informed consent was obtained before cesarean section (CS). All obstetricians involved in patients' management were free to choose one of the two conservative methods if there is no excessive intra-operative bleeding and after successful separation of most of the placenta. The primary outcome was the the rate of effectiveness of both procedures to conserve the uterus. The secondary outcomes were the mean intra-operative blood loss, the need for blood transfusion, the need for hysterectomy, the time of operation, the mean postoperative hemoglobin level and the duration of hospital stay RESULTS: Fifty eight women were included in the study; 33 women in the multiple 8 compression sutures group and 25 women in the transverse B-Lynch group. No difference between both groups regarding the baseline characteristics.
Transverse B-lynch suture was effective in 23/25 women (92%) while multiple 8 compression sutures was effective in 25/33 women (75.7%) (p¼0.01). The mean blood loss was significantly higher with multiple 8 compression sutures (1822.04AE653.7 vs. 1409.32AE445.05 ml, p¼0.015). Similarly, the amount of blood transfusion was higher in the same group (2160AE825.6 vs. 1620.3AE462.8 ml, p¼0.002). gonadotropin (hCG), alphafetoprotein (AFP), estriol, and inhibin multiple of the medians (MoMs) were collected, with abnormal levels defined as PAPP-A, 1 st trimester hCG, and estriol <5%ile, and AFP, 2 nd trimester hCG, and inhibin >95%ile for the cohort. Adverse outcomes were preterm delivery (PTD) < 37 and < 34 weeks gestation, small for gestational age (birthweight <10%ile), and pregnancy-associated hypertensive disease (preeclampsia, gestational hypertension, chronic hypertension with superimposed preeclampsia). Associations between abnormal analyte levels and outcomes, stratified by chorionicity, were calculated using chi-square or Fisher's exact test. RESULTS: Of 1060 twins delivered during the study interval, 480 (45.3%) had available analytes and met inclusion criteria -357 dichorionic/diamniotic (di/di) and 123 monochorionic/diamniotic (mono/di). Second trimester analytes were available for all while 249 (51.9%) and 167 (34.8%) women had PAPP-A and 1 st trimester beta-hCG respectively. Among di/di twins, elevated AFP (>3.70 MoM) was associated with increased PTD < 34 weeks (44.4 vs 16.5%, P ¼ 0.007) while elevated inhibin (>4.95 MoM) was associated with increased PTD < 37 weeks (94.1 vs 58.8%, P ¼ 0.004). For mono/di twins, elevated inhibin (>6.34 MoM) was associated with an increased PTD < 34 weeks (66.7 vs 24.8%, P¼0.04) and hypertensive disease (66.7 vs 21.4%, P¼0.03). There were no associations between adverse outcomes and other analytes. CONCLUSION: Elevated AFP and inhibin in twin pregnancies were associated with increased risks for PTD and pregnancy-associated hypertensive disease, though these associations differed by chorionicity. Such findings may contribute to the ability to identify twin pregnancies at increased risk for adverse outcomes.
128 Maternal and perinatal outcomes by gestational age with expectant management of full-term low -risk nulliparas
Alan T. Tita
Eunice Kennedy Shriver NICHD Maternal-Fetal Medicine Units Network, Bethesda, MD OBJECTIVE: To compare risks of selected maternal and perinatal outcomes by completed week of gestation (GA) after 39 weeks in low-risk nulliparas undergoing expectant management (EM). STUDY DESIGN: Planned secondary analysis of a multicenter RCT of induction of labor (IOL) at 39 0/7 wks vs. EM until at least 40 5/7 wks but no later than 42 2/7 in low-risk nulliparas. Only women with nonanomalous neonates, who were randomized to and proceeded with EM, and who attained 39 0/7 wks were included in this analysis. Delivery GA was categorized by completed wk (39, 40 and !41) and by labor mode (spontaneous vs. medically-indicated). Outcomes were: a) maternal, including cesarean (CD) and an adverse composite outcome and b) perinatal outcomes, including a perinatal composite and NICU admission. Categorical variables were compared using Cochran-armitage trend or Chi-Square test, and continuous variables using a Jonckheere Terpstra test. For multivariable analysis we applied Poisson regression. RESULTS: A total of 2518 women met eligibility criteria for this analysis. Overall, 39% delivered at 39 wks, 44% at 40 wks (73% of all remaining) and 17% at !41 wks (Table 1) . Spontaneous labor occurred in 62.3%. The prevalence of medically-indicated delivery (including post-dates) increased with GA (Table 1) . Apart from postdates, hypertensive disorders of pregnancy (HDP) and PROM were the most common indications for delivery at 39 and 40 wks. Baseline characteristics differed by delivery GA (Table 1) , with the frequencies of Bishop score <5 and smoking, and the medians of age and BMI increasing with GA. The frequency of CD and the perinatal composite increased with increasing GA (Table 2) . Additionally, when comparing outcomes of deliveries at each GA vs. deliveries at subsequent GAs (aRR; 95% CI), CD was significantly lower at 39 wks (0.68; 0.58, 0.80) and 40 wks (0.64; 0.55, 0.76). CONCLUSION: Although most women undergoing EM after 39 weeks labor spontaneously, the likelihood of CD and adverse perinatal composite outcome increase with GA.
